Login / Signup

Japanese subgroup analysis of GLIMMER: A global Phase IIb study of linerixibat for the treatment of cholestatic pruritus in patients with primary biliary cholangitis.

Atsushi TanakaMasanori AtsukawaKeiji TsujiKazuo NotsumataAkari SuyamaHiroshi ItoSugato DasRobyn von MaltzahnMegan M McLaughlin
Published in: Hepatology research : the official journal of the Japan Society of Hepatology (2023)
NCT02966834.
Keyphrases
  • liver injury
  • randomized controlled trial
  • drug induced
  • smoking cessation